Regardless of atopy, most Caucasian patients with CRSwNP in Western countries exhibit type-2 immune responses with a tendency toward comorbidities characterized by elevated IL-4, IL-5, IL-13, and local IgE production and profound tissue eosinophilia. The gene discussed is IL4; the disease is chronic rhinosinusitis with nasal polyps.